A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer

from the IV mb, by yyy60:

>>A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer

People with pancreatic cancer that cannot be cured by surgery are being asked to participate in this study. The purpose of this study is to test the ability of the radiation oncologists to administer Cyberknife therapy along with Gemcitabine chemotherapy for patients with pancreatic cancer. Radiation and Gemcitabine are both effective at killing cancer cells but they generally cannot be given at...

Date First Received: January 15, 2010
Clinical Trial Phase: Phase 1 | Start Date: November 2009
Last Updated: January 15, 2010
Overall Status: Recruiting
Verified by: Georgetown University, January 2010
Estimated Enrollment: 10


Brief Summary

Official Title: “A Pilot Study of Full Dose Gemcitabine and Hypofractionated Stereotactic Radiosurgery in the Treatment of Unresectable Pancreatic Cancer”

People with pancreatic cancer that cannot be cured by surgery are being asked to participate in this study.

The purpose of this study is to test the ability of the radiation oncologists to administer Cyberknife therapy along with Gemcitabine chemotherapy for patients with pancreatic cancer.

Radiation and Gemcitabine are both effective at killing cancer cells but they generally cannot be given at the same time. Cyberknife therapy is highly focused radiation that is being used extensively at Georgetown University and around the United States to treat a number of cancers. It is believed that because Cyberknife is so highly focused it can be given safely with regular doses of chemotherapy to attack cancer cells in two ways at the same time.

This research is being done because it is not known if using Cyberknife with chemotherapy will be a safe way to treat pancreatic cancer.

Study Type: Interventional

Study Design: Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Safety Study

Study Primary Completion Date: May 2010